Ticlopidine-induced cholestasis;Ticlopidin-induzierte cholestase

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 39, 1999, Pages 1405-1409

  Meyer, M I ^a,c   Kuhn, M ^b   Buhler H ^a   Bertschinger, Ph ^a  

^a Gastroenterologische Abteilung   (Switzerland)

^b Schweizerische Arzneimittel N   (Switzerland)

^c Stadtspital Waid   (Switzerland)

Author keywords

Cholestasis; Platelet aggregation inhibitors (adverse effects); Ticlopidine; Ticlopidine induced cholestasis; Toxic hepatitis; Toxic liver damage after ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ISOSORBIDE DINITRATE; METOPROLOL; TICLOPIDINE;

ACUTE HEART INFARCTION; AGED; ARTICLE; CASE REPORT; CHOLESTASIS; CORONARY ARTERY DISEASE; DRUG INDUCED DISEASE; HUMAN; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; STENT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ASPIRIN; CHOLESTASIS; DRUG THERAPY, COMBINATION; HEPATITIS, TOXIC; HUMANS; INCIDENCE; ISOSORBIDE DINITRATE; LIVER FUNCTION TESTS; MALE; METOPROLOL; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE;

EID: 0033517512     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bruno JJ. The mechanisms of action of ticlopidine. Thromb Res 1983;Suppl IV:59-87.
2. Panak E, Maffrand JP, Picard-Fraire C, Vallee E, Blanchard J, Roncucci R. Ticlopidine: a promise for the prevention and treatment of thombosis an its complications. Haemostasis 1983;31(Suppl 1):1-54.
3. Saltiel R, Ward A. Ticlopidine: a review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in platelet-dependent disease states. Drugs 1987; 34: 222-62.
4. Arzneimittelkompendium der Schweiz. 1999:2361-63.
5. Stricker BHC. Drug-induced hepatic injury. 2nd ed. Amsterdam: Eisevier; 1992. p. 343-4.
6. Gent M, Easton JD, Hachinski VC, Panak E, Sicurella J, Blakely JA, et al. The Canadian American Ticlopidin Study (CATS) in thromboembolic stroke. Lancet 1989;3:1215-20.
7. Deschamps JP, Lassègue A, Ottignon Y, Vuitton D, Allemand H, Carayon P, et al. Ictère cholestatique associé àla prise de ticlopidine: à propos des deux premiers cas. Gastroentereol Clin Biol 1982;6:595-6.
8. Eugène C, Lefebvre JF, Gury B, Quevauvilliers J. Hépatite cholestatique. Rôle vraisemblable de la ticlopidine. Sem Hôp Paris 1983;59:2923-4.
9. Greaney JJ, Hess DA, Mahoney CD. Ticlopidine-induced cholestatic jaundice. Clin Pharm 1993:12:398-9.
10. Nurhussein MA. Ticlopidine-induced prolonged cholcstasis. J Am Geriatr Soc 1993;41:1371-2.
11. Grimm IS, Litynski JJ. Severe cholestasis associated with ticlopidine. Am J Gastroenterol 1994;89:279-80.
12. Weber E, Donckier J. Ictère cholestatique sur ticlopidine: un nouveau cas.. Acta Clin Belg 1994;49:309-10.
13. Yoder JD, Algozzine CJ, Hill GW. More ticlopidine-induced cholestatic jaundice. Am J Hosp Pharm 1994;51:1821-2.
14. Colivicchi F, Magnanimi S, Sebastiani F, Silvestri R, Magnanimi R. Ticlopidine-induced chronic cholestatic hepatitis: a case report. Curr Ther Res 1994;55:929-31.
15. Cassidy LJ, Schuster BG, Halparin LS. Probable ticlopidineinduced cholestatic hepatitis. Ann Pharmacother 1995;29: 30-2.
16. Naschitz JE, Khamessi R, Elias N, Yeshurun D. Ticlopidineinduced prolonged cholestasis. J Toxicol Clin Toxicol 1995; 33:379-80.
17. Alvaro D, Gigliozzi A, Gaudio E, Pescarmona E, Ripani M, Peri C, et al. Ticlopidine-induced cholestasis: report of two cases and experimental evidence of the drug's adverse effect in isolated perfused rat liver. Eur J Gastroenterol Hepatol 1994;6:943-50.
18. Guzzini F, Baufi L, Gomitoni A, Marchegiani C, Novati P, Mesina M, et al. 2 cases of an acute cholestasis caused by ticlopidine. Recenti Prog Med 1997;88:124-7.
19. Wegmann C, Münzenmaier R, Dormann AJ, Huchzermeyer H. Ticlopidin-induzierte akute cholestatische Hepatitis. Dtsch Med Wochenschr 1998;123:146-50.
20. Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S, et al. A randomized trial comparing ticlopidine hydrochlorid with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-7.
21. Alvaro D, Gigliozzi A, Gaudio E, Franchitto A, Peri C, Bini A, et al. Repeated administration of ticlopidine promotes cholestasis in the isolated perfused rat liver. Hepatol 1994; 19:391-2.